Thinker. Investor. Satire. Advocate of the Ladder-adjusted risk premium
Jun 1, 2022 • 13 tweets • 3 min read
Going all-in on Spike-only antigen approaches (vaccines, neutralizing antibodies) both missed the mark and extended the pandemic
"Research suggests that vaccination against COVID via mRNA vaccines may reduce body's ability to produce key type of antibody" israelnationalnews.com/news/328102
"Vaccines against the coronavirus may impair the body’s ability to produce a key type of antibody, thus potentially limiting the immune system’s defenses against mutated strains of the virus, a new study suggests"
Data from Moderna’s mRNA SARS-CoV-2 vaccine RCT, July 20 - Mar 21
finance.yahoo.com/news/tonix-pha…
Yesterday at market close, $TNXP, a $42M company announced a share repurchase program worth up to $12.5M or 30% of it's value